Smoking influence on early and late fetal growth

Beatriz Fernandez-Rodriguez1, Ana Roche Gomez2, Blanca Sofia Jimenez Moreno2

  • 1Department of Pediatrics, University Hospital Del Tajo, Aranjuez, Madrid, Spain.

Insights

Smoking during pregnancy is linked to fetal growth restriction (FGR) and low birthweight after 34 weeks. This study found no significant association in earlier deliveries, highlighting a critical gestational window for intervention.

Area of Science:

  • Obstetrics and Gynecology
  • Perinatal Medicine
  • Maternal-Fetal Medicine

Background:

  • Smoking during pregnancy is a significant, modifiable risk factor for adverse fetal outcomes.
  • Fetal growth restriction (FGR) and low birthweight are leading causes of neonatal morbidity and mortality.
  • Understanding the impact of maternal smoking on fetal development across gestation is crucial.

Purpose of the Study:

  • To investigate the association between maternal smoking and the development of early (<34 weeks) and late (>34 weeks) fetal growth restriction (FGR) or low birthweight.
  • To examine the effects of smoking on uteroplacental and fetoplacental hemodynamics in growth-restricted fetuses.

Main Methods:

  • Retrospective cohort study of 5,537 singleton pregnancies.
  • Pregnancies categorized into early (<34 weeks) and late (>34 weeks) delivery groups.
  • FGR diagnosed using customized fetal growth standards and fetal Doppler; birthweight assessed with the Olsen newborn chart.

Main Results:

  • In late deliveries (>34 weeks), smoking was significantly associated with FGR (5% vs 1.3%, p<0.001) and lower birthweights (<3rd and <10th centiles).
  • Late FGR in smokers showed higher umbilical artery Doppler resistances.
  • No significant association between smoking and FGR, birthweight, or hemodynamics was found in early deliveries (<34 weeks).

Conclusions:

  • Maternal smoking is associated with increased risk of FGR, low birthweight, and altered fetal hemodynamics after 34 weeks gestation.
  • The detrimental effects of smoking on fetal growth appear more pronounced in later stages of pregnancy.
  • Interventions to reduce smoking during pregnancy may be particularly impactful for preventing late-onset FGR.
Abstract

Related Concept Videos

Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
71
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
597
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
540
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.0K